Item 16. FORM 10-K SUMMARY

2K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



	THE CLOROX COMPANY

Date: August 14, 2018	By:	/s/ Benno Dorer
		Benno Dorer
		Chairman and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



Signature	Title	Date
/s/ A. Banse	Director	August 14, 2018
A. Banse
/s/ R. H. Carmona	Director	August 14, 2018
R. H. Carmona
/s/ S. C. Fleischer	Director	August 14, 2018
S. C. Fleischer
/s/ E. Lee	Director	August 14, 2018
E. Lee
/s/ A. D. D. Mackay	Director	August 14, 2018
A. D. D. Mackay
/s/ R. W. Matschullat	Director	August 14, 2018
R. W. Matschullat
/s/ J. Noddle	Director	August 14, 2018
J. Noddle
/s/ M. J. Shattock	Director	August 14, 2018
M. J. Shattock
/s/ P. Thomas-Graham	Director	August 14, 2018
P. Thomas-Graham
/s/ C. M. Ticknor	Director	August 14, 2018
C. M. Ticknor
/s/ R. J. Weiner	Director	August 14, 2018
R. J. Weiner
/s/ C. J. Williams	Director	August 14, 2018
C. J. Williams
/s/ B. Dorer	Chairman and Chief Executive Officer (Principal Executive Officer)	August 14, 2018
B. Dorer
/s/ K. B. Jacobsen	Senior Vice President – Chief Financial Officer (Principal Financial Officer)	August 14, 2018
K. B. Jacobsen
/s/ J. R. Baker	Vice President – Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)	August 14, 2018
J. R. Baker

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES